Navigation Links
Alcoholism Drug Fails To Prevent Drinking Relapses

The Food and Drug Administration approved naltrexone for the treatment of alcoholism in 1994. At that time, the only other drug therapy available was disulfiram, or Antabuse, which provokes a sickening reaction to alcohol.// A new study casts sobering doubts on earlier claims that an alcoholism drug can truly treat the addiction.

The government is sponsoring a large trial comparing naltrexone, which is also used to treat heroin addiction, with another alcoholism drug, acamprosate. Both medications act on the brain's opioid receptors to make drinking less pleasurable.

Earlier studies, including the work that led to its FDA approval, showed that when combined with counseling naltrexone could help control alcoholism by reducing drinking days and increasing days without liquor. The drug was also shown to suppress cravings and prevent relapses. In fact, the latest study was intended to learn not whether the drug was effective, which was assumed, but for how long. The study says naltrexone fails to prevent drinking relapses, and in fact is no better than sugar pills at keeping hardened alcoholics on the wagon.
'"/>




Page: 1

Related medicine news :

1. Alcoholism Influenced By Both Genetics & Family Environment
2. Detrimental Effect Of Chronic Alcoholism On Male Fertility
3. Smoking And Its Relation To Neurocognitive Deficits In Alcoholism
4. Alcoholism Linked To Higher Death Rates Among Older Men
5. Alcoholism Drug Vivitrol Approved By FDA
6. Is Alcoholism Genetic?
7. Alcoholism & Dependence Seen More Commonly In Early Alcohol Drinkers
8. Study to Identify People at Risk of Alcoholism
9. Mother’s Drinking May Increase Childs Alcoholism Ris
10. Good drinkers have Higher Risk of Alcoholism
11. Effective Cure for Alcoholism – A single dose of LS

Post Your Comments:
(Date:11/10/2009)...versity Rollins School of Public Health researcher... American Public Health Association,s annual meeti...d compliance with national recommendations that a ...utes of their arrival to the Emergency Department ...gs from Emory scientists are highlighted below. ,...
(Date:11/9/2009)... Businesses of all sizes looking to fast-trac...andemic have a new resource at their disposal. , ...ber 9, 2009 -- Human resource (HR) professionals l...orts for the H1N1 pandemic have a new resource at ...s Center for Infectious Disease Research and Polic...
(Date:11/9/2009)... Tarkett Sports, the worldwide leader in spor...roduct offering with a more complete and innovativ...indoor sports flooring experts and the launch of ... (PRWEB) November 9, 2009 -- Tarkett Sports,...looring products includes hardwood and synthetic b...
(Date:11/9/2009)...ed by USDA Secretary Vilsack, Governor Patrick, an... In a groundbreaking mo...ern (D-Worcester) called for all of the state,s ho...atients in their care. ,, "With 554,000 people...n at today,s press conference at UMass Memorial He...
(Date:11/9/2009)...s on Election Promise. Now Is Time for Senate to A...e/ -- The following is a statement by Anna Burger,...struggle and decades of delay, the U.S. House of R...ass historic reform legislation to assure every Am...h quality, affordable health care. The House,s act...
Breaking Medicine News(10 mins):Health News:Some chest pain patients wait longer than 10 minutes to see ER physician 2Health News:New H1N1 Flu Guide Offers Practical Tools and Tips for HR Professionals 2Health News:New H1N1 Flu Guide Offers Practical Tools and Tips for HR Professionals 3Health News:Tarkett Sports Launches Revamped Indoor Sports Flooring Division and New Indoor Website 2Health News:McGovern and Project Bread Launch Hospital Hunger Initiative 2Health News:McGovern and Project Bread Launch Hospital Hunger Initiative 3Health News:Statement of Anna Burger, Chair, Change to Win, on U.S. House Vote for Health Care Reform 2
... in adult field guidelines also ...March 8 New guidelines for on-field,treatment and...ted neck,injuries should recommend keeping both he... to new research released,today at the 2008 Americ...
...ill,publish a series of articles next week regardi...ls in drinking water. While the issue of,pharmaceu...new, the series,may prompt concern among consumers...ater community is protecting public health.,As par...
...ohibition on to Mental Health ...In a stunning move, the,U.S. House of Representati... from being admitted to some of the Nation,s best ...be the long-awaited,passage of a Mental Health Par...
...nternational Development and USAID Administrator H...uests at an International Women,s Day,celebration ...portunity to,celebrate the advancement of women th...to ensure women,s equality in,every country., "To...
...ke Force, WASHINGTON, March 7 A federal jury in ...rators of two durable medical,equipment companies ...sistant Attorney General Alice S. Fisher of the Cr...y found Maria T. Hernandez,(Mayte), 50, Marta F. J...
...nc. today,announced that on Thursday, March 13, 20... year 2007 financial results before the open of th...ompany will hold a conference,call on Thursday, Ma...ident and Chief Financial Officer, will host,the c...
Other Medicine News:Health News:Study Reveals Emergency On-Field Treatment for Neck Injuries in Young Collision Sports Athletes No Different Than Adults 2Health News:U.S. House Votes to Block Medicare Recipients From Access to Over 200 of America's Best and Safest Hospitals. 2Health News:First Lady Honors Women at International Women's Day Event 2Health News:Miami Jury Convicts Physician and Three Business Owners of Medicare Fraud 2Health News:Miami Jury Convicts Physician and Three Business Owners of Medicare Fraud 3
(Date:11/10/2009)... JumpStart Inc., the Northeast Ohio venture develo...f high growth early-stage businesses, announced a ...00 in Checkpoint Surgical, LLC. A spinout of NDI M...any is developing and commercializing a surgical h... http://www.newscom.com/cgi-bin/prnh/20060209/CL...
(Date:11/10/2009)... Ironwood Pharmaceuticals, Inc. and...ve entered into an agreement providing Astellas ex...vestigational compound linaclotide in Japan, Indon.... Linaclotide is currently in Phase 3 clinical dev... irritable bowel syndrome with constipation (IBS-C...
(Date:11/9/2009)...re-FirstCall/ -- Thoratec Corporation (Nasdaq: TH...rculatory support therapies to save, support and r...participating in the Third Annual Canaccord Cardio... The presentation by Gary F. Burbach, president an...acific Standard Time (11 a.m., Eastern Standard Ti...
Breaking Medicine Technology:JumpStart Invests in Checkpoint Surgical 2JumpStart Invests in Checkpoint Surgical 3Ironwood and Astellas Announce Japan Licensing Agreement for Linaclotide 2Ironwood and Astellas Announce Japan Licensing Agreement for Linaclotide 3Silas Home Care Selects Cardiocom Telehealth Technology 52084 1Silas Home Care Selects Cardiocom Telehealth Technology 52084 2ATS Medical Announces First Use of the New ATS CryoMaze 10 S Probe 52081 1ATS Medical Announces First Use of the New ATS CryoMaze 10 S Probe 52081 2ATS Medical Announces First Use of the New ATS CryoMaze 10 S Probe 52081 3ATS Medical Announces First Use of the New ATS CryoMaze 10 S Probe 52081 4Bioniche Repays Revolving Credit Facility 52077 1Bioniche Repays Revolving Credit Facility 52077 2
... 12 Boston,Scientific Corporation (NYSE: BSX ) t...7,500 patients from its TAXUS ARRIVE 1 and 2 regis...ce of the TAXUS(R) Express2(TM),Paclitaxel-Eluting...,two-year pooled ARRIVE data showed that the TAXUS...h diabetes as effectively as in patients without,d...
...entific,Corporation (NYSE: BSX ) today announced ...ss announcements at the Cardiovascular Research Fo...rdiovascular Therapeutics (TCT),scientific symposi..., D.C., Boston Scientific will be announcing a wi...R) Express2(TM) and second-generation TAXUS(R),Lib...
Other Medicine Technology:TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 2TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 3TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 4TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 5Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 2Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 3Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 4Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 5Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 6
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
Medicine Products: